![HIGHLIGHTS OF PRESCRIBING INFORMATION](http://s1.studyres.com/store/data/008029230_2-dc0efaebaa03dc1045150e6a17bc150b-300x300.png)
HIGHLIGHTS OF PRESCRIBING INFORMATION
... The safety and effectiveness of RISPERDAL® in pediatric patients with autistic disorder less than 5 years of age have not been established. The dosage of RISPERDAL® should be individualized according to the response and tolerability of the patient. The total daily dose of RISPERDAL® can be administe ...
... The safety and effectiveness of RISPERDAL® in pediatric patients with autistic disorder less than 5 years of age have not been established. The dosage of RISPERDAL® should be individualized according to the response and tolerability of the patient. The total daily dose of RISPERDAL® can be administe ...
Unit Assessment Keyed for Instructors
... • Direct students to visit the companion website to Nancy Caroline’s Emergency Care in the Streets, Seventh Edition, at http://www.paramedic.emszone.com for online activities. • The Federal Food and Drug Administration website: http://www.fda.gov/ • Content connections: The chapter on Medication Adm ...
... • Direct students to visit the companion website to Nancy Caroline’s Emergency Care in the Streets, Seventh Edition, at http://www.paramedic.emszone.com for online activities. • The Federal Food and Drug Administration website: http://www.fda.gov/ • Content connections: The chapter on Medication Adm ...
PRILOSEC (omeprazole) (omeprazole magnesium) DELAYED-RELEASE CAPSULES
... antibacterial agents. For more information specific to antibacterial agents (clarithromycin and amoxicillin) indicated for use in combination with PRILOSEC, refer to WARNINGS and PRECAUTIONS sections of those package inserts. 5.4 Interaction with Clopidogrel Avoid concomitant use of PRILOSEC with cl ...
... antibacterial agents. For more information specific to antibacterial agents (clarithromycin and amoxicillin) indicated for use in combination with PRILOSEC, refer to WARNINGS and PRECAUTIONS sections of those package inserts. 5.4 Interaction with Clopidogrel Avoid concomitant use of PRILOSEC with cl ...
Warfarin – INR – Antibiotic Interactions
... increase INR and the effects of warfarin ***S-warfarin is 2-5 times more active than the R-enantiomer Related Information: A challenging aspect of warfarin management has always been keeping patients’ INR within the therapeutic window. Once on a stable dose of warfarin, numerous factors can affect I ...
... increase INR and the effects of warfarin ***S-warfarin is 2-5 times more active than the R-enantiomer Related Information: A challenging aspect of warfarin management has always been keeping patients’ INR within the therapeutic window. Once on a stable dose of warfarin, numerous factors can affect I ...
Role of sotalol in rhythm control of atrial fibrillation
... age and food have slight but insignificant effects on bioavailability. Sotalol plasma levels and half-life are directly related to creatinine clearance and glomerular filtration rate [41,43,44] ; therefore, lower doses are necessary in conditions of renal impairment. In patients with normal renal fu ...
... age and food have slight but insignificant effects on bioavailability. Sotalol plasma levels and half-life are directly related to creatinine clearance and glomerular filtration rate [41,43,44] ; therefore, lower doses are necessary in conditions of renal impairment. In patients with normal renal fu ...
75002402 - lopinavir and ritonavir tabs - outsert
... prolapse or left ventricular hypertrophy. It is recommended that armodafinil tablets not be used in patients with a history of left ventricular hypertrophy or in patients with mitral valve prolapse who have experienced the mitral valve prolapse syndrome when previously receiving CNS stimulants. Find ...
... prolapse or left ventricular hypertrophy. It is recommended that armodafinil tablets not be used in patients with a history of left ventricular hypertrophy or in patients with mitral valve prolapse who have experienced the mitral valve prolapse syndrome when previously receiving CNS stimulants. Find ...
Plavix - Sanofi Canada
... In patients with recent transient ischaemic attack (TIA) or stroke and who are at high risk of recurrent ischemic events, the combination of ASA and PLAVIX has not been shown to be more effective than PLAVIX alone, but the combination has been shown to increase major bleeding (see DRUG INTERACTIONS ...
... In patients with recent transient ischaemic attack (TIA) or stroke and who are at high risk of recurrent ischemic events, the combination of ASA and PLAVIX has not been shown to be more effective than PLAVIX alone, but the combination has been shown to increase major bleeding (see DRUG INTERACTIONS ...
Diamorphine Hydrochloride BP 100 mg Lyophilisate for solution for
... Diamorphine has been used in the treatment of terminally ill children. Diamorphine has been administered in reduced doses to children with neoplastic disease when it becomes difficult to give treatment orally. The starting dose should be selected according to age, size, symptoms and previous analges ...
... Diamorphine has been used in the treatment of terminally ill children. Diamorphine has been administered in reduced doses to children with neoplastic disease when it becomes difficult to give treatment orally. The starting dose should be selected according to age, size, symptoms and previous analges ...
Antidote–Opioids
... Naltrexone is rapidly absorbed with an oral bioavailability of 5% to 60%, and peak serum concentrations occur at 1 hour.34 Distribution is rapid, with a Vd of approximately 15 L/kg and low protein binding.45 Naltrexone is metabolized in the liver to β-naltrexol (with 2%–8% activity) and 2hydroxy, 3 ...
... Naltrexone is rapidly absorbed with an oral bioavailability of 5% to 60%, and peak serum concentrations occur at 1 hour.34 Distribution is rapid, with a Vd of approximately 15 L/kg and low protein binding.45 Naltrexone is metabolized in the liver to β-naltrexol (with 2%–8% activity) and 2hydroxy, 3 ...
PRODUCT MONOGRAPH COMBIGAN®
... Because of the timolol maleate component, cardiac failure should be adequately controlled before beginning therapy with COMBIGAN®. In patients with a history of severe cardiac disease, signs of cardiac failure should be watched for and pulse rates should be checked. Caution should be exercised in tr ...
... Because of the timolol maleate component, cardiac failure should be adequately controlled before beginning therapy with COMBIGAN®. In patients with a history of severe cardiac disease, signs of cardiac failure should be watched for and pulse rates should be checked. Caution should be exercised in tr ...
sodium valproate - World Health Organization
... USA, in around 1990, found the annual incident rate to be 20/100,000 in whites, and 57/100,000 in non-whites4, but it is difficult to extrapolate this to the rates which would be expected in different countries. There seem to be no studies of the incidence of status epilepticus in resource-poor coun ...
... USA, in around 1990, found the annual incident rate to be 20/100,000 in whites, and 57/100,000 in non-whites4, but it is difficult to extrapolate this to the rates which would be expected in different countries. There seem to be no studies of the incidence of status epilepticus in resource-poor coun ...
Buprenorphine and Naloxone: Clinical Pharmacology Abuse Liability
... measurable Naloxone levels Almost no Naloxone detectable in plasma with either PO or SL doses – Naloxone found in only 4 of 144 samples after PO, 6 of 144 after SL – Estimated SL F is only 3%, oral F ...
... measurable Naloxone levels Almost no Naloxone detectable in plasma with either PO or SL doses – Naloxone found in only 4 of 144 samples after PO, 6 of 144 after SL – Estimated SL F is only 3%, oral F ...
Article PDF - Open Access Peer Reviewed Medical
... compared to younger patients. Daptomycin, a cyclic lipopeptide, exhibits excellent in vitro bactericidal activity against MRSA and other Gram-positive bacteria associated with complicated skin and skin structure infections (cSSSI). Daptomycin achieves adequate drug penetration into inflamed soft tis ...
... compared to younger patients. Daptomycin, a cyclic lipopeptide, exhibits excellent in vitro bactericidal activity against MRSA and other Gram-positive bacteria associated with complicated skin and skin structure infections (cSSSI). Daptomycin achieves adequate drug penetration into inflamed soft tis ...
Oxycodone and Acetaminophen Tablets USP 5
... products. The risk of acute liver failure is higher in individuals with underlying liver disease and in individuals who ingest alcohol while taking acetaminophen. Instruct patients to look for acetaminophen or APAP on package labels and not to use more than one product that contains acetaminophen. I ...
... products. The risk of acute liver failure is higher in individuals with underlying liver disease and in individuals who ingest alcohol while taking acetaminophen. Instruct patients to look for acetaminophen or APAP on package labels and not to use more than one product that contains acetaminophen. I ...
SCIENTIFIC DISCUSSION 1. Introduction Fungal infections have
... of the efflux pump genes. These isolates had nonsense mutations in the ERG3 gene resulting in a nonfunctional ∆5,6-sterol desaturase, thereby abrogating the toxicity of the methylated sterol intermediates. This mechanism of resistance was rarely observed. ...
... of the efflux pump genes. These isolates had nonsense mutations in the ERG3 gene resulting in a nonfunctional ∆5,6-sterol desaturase, thereby abrogating the toxicity of the methylated sterol intermediates. This mechanism of resistance was rarely observed. ...
Prescribing Information REYATAZ TM 150 mg REYATAZ TM 200 mg
... In healthy volunteers and in patients, abnormalities in atrioventricular (AV) conduction were asymptomatic and generally limited to first-degree AV block. There have been reports of seconddegree AV block and other conduction abnormalities [see Adverse Reactions (6.4) and Overdosage (10)]. In clinica ...
... In healthy volunteers and in patients, abnormalities in atrioventricular (AV) conduction were asymptomatic and generally limited to first-degree AV block. There have been reports of seconddegree AV block and other conduction abnormalities [see Adverse Reactions (6.4) and Overdosage (10)]. In clinica ...
CARISOPRODOL Tablets, USP Rx Only
... who received carisoprodol experienced sedation compared to 6% of patients who received placebo) [see ADVERSE REACTIONS (6.1)] and may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a motor vehicle or operating machinery. There ...
... who received carisoprodol experienced sedation compared to 6% of patients who received placebo) [see ADVERSE REACTIONS (6.1)] and may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a motor vehicle or operating machinery. There ...
Patient Information Instructions for Use
... therapy than in patients treated with etanercept alone. Use of Kineret in combination with TNF blocking agents is not recommended (7) -----------------USE IN SPECIFIC POPULATIONS---------------• Pediatric use: Kineret is indicated for use in pediatric patients with NOMID (8.4) • Geriatri ...
... therapy than in patients treated with etanercept alone. Use of Kineret in combination with TNF blocking agents is not recommended (7) -----------------USE IN SPECIFIC POPULATIONS---------------• Pediatric use: Kineret is indicated for use in pediatric patients with NOMID (8.4) • Geriatri ...
FULL PRESCRIBING INFORMATION
... with ADHD should be treated with dexmethylphenidate hydrochloride extended-release capsules. It is generally agreed, however, that pharmacological treatment of ADHD may be needed for extended periods. Nevertheless, the physician who elects to use dexmethylphenidate hydrochloride extended-release cap ...
... with ADHD should be treated with dexmethylphenidate hydrochloride extended-release capsules. It is generally agreed, however, that pharmacological treatment of ADHD may be needed for extended periods. Nevertheless, the physician who elects to use dexmethylphenidate hydrochloride extended-release cap ...
HYDROMORPHONE HYDROCHLORIDE TABLETS USP 2 mg, 4
... Tolerance is the need for increasing doses of opioids to maintain a defined effect such as analgesia (in the absence of disease progression or other external factors). Physical dependence is manifested by withdrawal symptoms after abrupt discontinuation of a drug or upon administration of an antagon ...
... Tolerance is the need for increasing doses of opioids to maintain a defined effect such as analgesia (in the absence of disease progression or other external factors). Physical dependence is manifested by withdrawal symptoms after abrupt discontinuation of a drug or upon administration of an antagon ...
Product Monograph
... Cipralex has not been systematically evaluated in patients with a seizure disorder. These patients were excluded from the clinical studies. In clinical trials with escitalopram oxalate, convulsions have been reported very rarely (2 out of 3981 patients) in association with treatment with escitalopra ...
... Cipralex has not been systematically evaluated in patients with a seizure disorder. These patients were excluded from the clinical studies. In clinical trials with escitalopram oxalate, convulsions have been reported very rarely (2 out of 3981 patients) in association with treatment with escitalopra ...
WELLBUTRIN SR
... placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 subjects. There was considerable variation in risk of suicidality among drugs, but a tendency toward an incre ...
... placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 subjects. There was considerable variation in risk of suicidality among drugs, but a tendency toward an incre ...
product monograph isoptin sr
... hydrochloride at doses up to 720 mg/day, a variety of serious adverse effects were seen. Three patients died in pulmonary edema; all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. Eight other patients had pulmonary edema and/or severe hypotension, ...
... hydrochloride at doses up to 720 mg/day, a variety of serious adverse effects were seen. Three patients died in pulmonary edema; all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. Eight other patients had pulmonary edema and/or severe hypotension, ...
Fentanyl Citrate Injection, USP
... the pregnancy rate of all experimental groups. This decrease was most pronounced in the high dose group (1.25 mg/kg–12.5X human dose) in which one of twenty animals became pregnant. Pregnancy – Category C: Fentanyl citrate has been shown to impair fertility and to have an embryocidal effect in rats ...
... the pregnancy rate of all experimental groups. This decrease was most pronounced in the high dose group (1.25 mg/kg–12.5X human dose) in which one of twenty animals became pregnant. Pregnancy – Category C: Fentanyl citrate has been shown to impair fertility and to have an embryocidal effect in rats ...
(2012, August). Potential prevention: Aloe vera
... Therefore, the author thinks the main reason that this study failed to find any beneficial effects of Aloe vera gel is due to its dosage form. In that study, Aloe vera gel was taken orally. Oral Aloe vera was absorbed in gastric and circulated into the blood. Therefore, oral Aloe vera acted as a sys ...
... Therefore, the author thinks the main reason that this study failed to find any beneficial effects of Aloe vera gel is due to its dosage form. In that study, Aloe vera gel was taken orally. Oral Aloe vera was absorbed in gastric and circulated into the blood. Therefore, oral Aloe vera acted as a sys ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.